List of Tables
Table 1. Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of DNA
Table 3. Key Players of RNA
Table 4. Key Players of Others
Table 5. Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Region (2019-2024)
Table 9. Global Novel Coronavirus (COVID-19) Vaccine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Region (2025-2030)
Table 11. Novel Coronavirus (COVID-19) Vaccine Market Trends
Table 12. Novel Coronavirus (COVID-19) Vaccine Market Drivers
Table 13. Novel Coronavirus (COVID-19) Vaccine Market Challenges
Table 14. Novel Coronavirus (COVID-19) Vaccine Market Restraints
Table 15. Global Novel Coronavirus (COVID-19) Vaccine Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Players (2019-2024)
Table 17. Global Top Novel Coronavirus (COVID-19) Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Coronavirus (COVID-19) Vaccine as of 2023)
Table 18. Ranking of Global Top Novel Coronavirus (COVID-19) Vaccine Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Novel Coronavirus (COVID-19) Vaccine Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Novel Coronavirus (COVID-19) Vaccine Product Solution and Service
Table 22. Date of Enter into Novel Coronavirus (COVID-19) Vaccine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Type (2019-2024)
Table 26. Global Novel Coronavirus (COVID-19) Vaccine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Type (2025-2030)
Table 28. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Application (2019-2024)
Table 30. Global Novel Coronavirus (COVID-19) Vaccine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Application (2025-2030)
Table 32. North America Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Novel Coronavirus (COVID-19) Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Novel Coronavirus (COVID-19) Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Novel Coronavirus (COVID-19) Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Novel Coronavirus (COVID-19) Vaccine Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Novel Coronavirus (COVID-19) Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Novel Coronavirus (COVID-19) Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Novel Coronavirus (COVID-19) Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Novel Coronavirus (COVID-19) Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 47. Inovio Pharmaceuticals Company Detail
Table 48. Inovio Pharmaceuticals Business Overview
Table 49. Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product
Table 50. Inovio Pharmaceuticals Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 51. Inovio Pharmaceuticals Recent Development
Table 52. Takis Biotech (Evvivax) Company Detail
Table 53. Takis Biotech (Evvivax) Business Overview
Table 54. Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product
Table 55. Takis Biotech (Evvivax) Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 56. Takis Biotech (Evvivax) Recent Development
Table 57. Zydus Cadila Company Detail
Table 58. Zydus Cadila Business Overview
Table 59. Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product
Table 60. Zydus Cadila Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 61. Zydus Cadila Recent Development
Table 62. Codagenix, Inc. Company Detail
Table 63. Codagenix, Inc. Business Overview
Table 64. Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 65. Codagenix, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 66. Codagenix, Inc. Recent Development
Table 67. GeoVax, Inc. Company Detail
Table 68. GeoVax, Inc. Business Overview
Table 69. GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 70. GeoVax, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 71. GeoVax, Inc. Recent Development
Table 72. Bravovax Company Detail
Table 73. Bravovax Business Overview
Table 74. Bravovax Novel Coronavirus (COVID-19) Vaccine Product
Table 75. Bravovax Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 76. Bravovax Recent Development
Table 77. Janssen Pharmaceutical Companies Company Detail
Table 78. Janssen Pharmaceutical Companies Business Overview
Table 79. Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product
Table 80. Janssen Pharmaceutical Companies Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 81. Janssen Pharmaceutical Companies Recent Development
Table 82. Altimmune Company Detail
Table 83. Altimmune Business Overview
Table 84. Altimmune Novel Coronavirus (COVID-19) Vaccine Product
Table 85. Altimmune Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 86. Altimmune Recent Development
Table 87. Vaxart Company Detail
Table 88. Vaxart Business Overview
Table 89. Vaxart Novel Coronavirus (COVID-19) Vaccine Product
Table 90. Vaxart Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 91. Vaxart Recent Development
Table 92. CanSino Biologics Company Detail
Table 93. CanSino Biologics Business Overview
Table 94. CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product
Table 95. CanSino Biologics Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 96. CanSino Biologics Recent Development
Table 97. ExpreS2ion Biotechnologies ApS Company Detail
Table 98. ExpreS2ion Biotechnologies ApS Business Overview
Table 99. ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Product
Table 100. ExpreS2ion Biotechnologies ApS Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 101. ExpreS2ion Biotechnologies ApS Recent Development
Table 102. Clover Biopharmaceuticals Company Detail
Table 103. Clover Biopharmaceuticals Business Overview
Table 104. Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product
Table 105. Clover Biopharmaceuticals Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 106. Clover Biopharmaceuticals Recent Development
Table 107. GSK Company Detail
Table 108. GSK Business Overview
Table 109. GSK Novel Coronavirus (COVID-19) Vaccine Product
Table 110. GSK Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 111. GSK Recent Development
Table 112. Vaxil Bio Ltd. Company Detail
Table 113. Vaxil Bio Ltd. Business Overview
Table 114. Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Product
Table 115. Vaxil Bio Ltd. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 116. Vaxil Bio Ltd. Recent Development
Table 117. Generex Company Detail
Table 118. Generex Business Overview
Table 119. Generex Novel Coronavirus (COVID-19) Vaccine Product
Table 120. Generex Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 121. Generex Recent Development
Table 122. Novavax, Inc. Company Detail
Table 123. Novavax, Inc. Business Overview
Table 124. Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 125. Novavax, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 126. Novavax, Inc. Recent Development
Table 127. Sanofi Pasteur Company Detail
Table 128. Sanofi Pasteur Business Overview
Table 129. Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Product
Table 130. Sanofi Pasteur Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 131. Sanofi Pasteur Recent Development
Table 132. Baylor Company Detail
Table 133. Baylor Business Overview
Table 134. Baylor Novel Coronavirus (COVID-19) Vaccine Product
Table 135. Baylor Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 136. Baylor Recent Development
Table 137. iBio, Inc. Company Detail
Table 138. iBio, Inc. Business Overview
Table 139. iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 140. iBio, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 141. iBio, Inc. Recent Development
Table 142. Moderna, Inc. Company Detail
Table 143. Moderna, Inc. Business Overview
Table 144. Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Product
Table 145. Moderna, Inc. Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 146. Moderna, Inc. Recent Development
Table 147. Curevac Company Detail
Table 148. Curevac Business Overview
Table 149. Curevac Novel Coronavirus (COVID-19) Vaccine Product
Table 150. Curevac Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 151. Curevac Recent Development
Table 152. ImmunoPrecise Company Detail
Table 153. ImmunoPrecise Business Overview
Table 154. ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Product
Table 155. ImmunoPrecise Revenue in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024) & (US$ Million)
Table 156. ImmunoPrecise Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Novel Coronavirus (COVID-19) Vaccine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Type: 2023 VS 2030
Figure 3. DNA Features
Figure 4. RNA Features
Figure 5. Others Features
Figure 6. Global Novel Coronavirus (COVID-19) Vaccine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Application: 2023 VS 2030
Figure 8. Mild Symptom Patient Case Studies
Figure 9. Critically Ill Patient Case Studies
Figure 10. Novel Coronavirus (COVID-19) Vaccine Report Years Considered
Figure 11. Global Novel Coronavirus (COVID-19) Vaccine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Novel Coronavirus (COVID-19) Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Region: 2023 VS 2030
Figure 14. Global Novel Coronavirus (COVID-19) Vaccine Market Share by Players in 2023
Figure 15. Global Top Novel Coronavirus (COVID-19) Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Coronavirus (COVID-19) Vaccine as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Novel Coronavirus (COVID-19) Vaccine Revenue in 2023
Figure 17. North America Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Novel Coronavirus (COVID-19) Vaccine Market Share by Country (2019-2030)
Figure 19. United States Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Novel Coronavirus (COVID-19) Vaccine Market Share by Country (2019-2030)
Figure 23. Germany Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Novel Coronavirus (COVID-19) Vaccine Market Share by Region (2019-2030)
Figure 31. China Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Novel Coronavirus (COVID-19) Vaccine Market Share by Country (2019-2030)
Figure 39. Mexico Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Novel Coronavirus (COVID-19) Vaccine Market Share by Country (2019-2030)
Figure 43. Turkey Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Novel Coronavirus (COVID-19) Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Inovio Pharmaceuticals Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 46. Takis Biotech (Evvivax) Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 47. Zydus Cadila Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 48. Codagenix, Inc. Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 49. GeoVax, Inc. Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 50. Bravovax Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 51. Janssen Pharmaceutical Companies Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 52. Altimmune Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 53. Vaxart Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 54. CanSino Biologics Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 55. ExpreS2ion Biotechnologies ApS Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 56. Clover Biopharmaceuticals Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 57. GSK Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 58. Vaxil Bio Ltd. Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 59. Generex Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 60. Novavax, Inc. Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 61. Sanofi Pasteur Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 62. Baylor Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 63. iBio, Inc. Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 64. Moderna, Inc. Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 65. Curevac Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 66. ImmunoPrecise Revenue Growth Rate in Novel Coronavirus (COVID-19) Vaccine Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed